China SXT Pharmaceuticals (SXTC) Non-Current Debt (2019 - 2025)
Historic Non-Current Debt for China SXT Pharmaceuticals (SXTC) over the last 6 years, with Q3 2025 value amounting to $73102.0.
- China SXT Pharmaceuticals' Non-Current Debt fell 3662.26% to $73102.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $73102.0, marking a year-over-year decrease of 3662.26%. This contributed to the annual value of $96264.0 for FY2025, which is 1781.37% down from last year.
- Latest data reveals that China SXT Pharmaceuticals reported Non-Current Debt of $73102.0 as of Q3 2025, which was down 3662.26% from $96264.0 recorded in Q1 2025.
- China SXT Pharmaceuticals' Non-Current Debt's 5-year high stood at $117862.0 during Q1 2023, with a 5-year trough of $6292.0 in Q1 2021.
- Its 4-year average for Non-Current Debt is $90366.9, with a median of $106575.0 in 2023.
- As far as peak fluctuations go, China SXT Pharmaceuticals' Non-Current Debt crashed by 8276.68% in 2021, and later skyrocketed by 822.8% in 2024.
- China SXT Pharmaceuticals' Non-Current Debt (Quarter) stood at $6292.0 in 2021, then soared by 1593.82% to $106575.0 in 2023, then increased by 8.23% to $115344.0 in 2024, then plummeted by 36.62% to $73102.0 in 2025.
- Its last three reported values are $73102.0 in Q3 2025, $96264.0 for Q1 2025, and $115344.0 during Q3 2024.